United States v. Roux Laboratories, Inc.

456 F. Supp. 973, 1978 U.S. Dist. LEXIS 15659
CourtDistrict Court, M.D. Florida
DecidedSeptember 7, 1978
Docket75-30-Misc-J
StatusPublished
Cited by9 cases

This text of 456 F. Supp. 973 (United States v. Roux Laboratories, Inc.) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Roux Laboratories, Inc., 456 F. Supp. 973, 1978 U.S. Dist. LEXIS 15659 (M.D. Fla. 1978).

Opinion

*975 OPINION

CHARLES R. SCOTT, District Judge.

In June, 1975, an administrative search warrant was issued by the Court, authorizing agents of the Food and Drug Administration (“FDA”) to inspect the premises of Roux Laboratories, Inc. (“Roux”), and to collect samples of identified raw material used in the manufacture of retail, hair dye products. That warrant was not honored by Roux. Instead, Roux resisted compliance with the warrant. A contempt hearing was held in 1975; but the case later became tangled in several discovery disputes, with opposing discovery motions and objections. The Court resolved those disputes in its order of August 19,1977. However, the Court did not reach the issue of Roux’s contempt, and has never ruled on that question.

Two months later, on October 19, 1977, a new administrative search warrant was issued by the Honorable Harvey E. Schlesinger, United States Magistrate. When FDA agents attempted to execute the warrant, on October 20, 1977, by inspecting the premises and collecting samples of raw materials, once again Roux resisted the search warrant. An order to show cause concerning contempt of the Court’s search was issued by Judge Schlesinger on October 27, 1977, following referral of contempt proceedings to him. Contempt hearings were held on November 3 and December 19,1977. The FDA and Roux were permitted to brief the issues. Those issues are (1) whether the FDA possesses the authority to collect samples of materials during administrative searches; (2) whether the eight ounce samples to be collected by FDA are unreasonable amounts; (3) whether the particular searches in 1975 and again in 1977 constitute harassment by FDA against Roux; and (4) whether Roux is, and should be held, in contempt of this Court’s search warrants.

On February 28, 1978, findings of fact, conclusions of law, and a recommendation that Roux be held in contempt of the Court’s October 19, 1977, search warrant were issued by Judge Schlesinger. Roux filed objections to those findings, conclusions and the recommendation on March 22, 1978. The Court has reviewed the transcripts of the contempt hearings before Judge Schlesinger, Roux’s objections, and Judge Schlesinger’s findings of fact and conclusions of law. The Court will rule on the four issues raised by Roux, and then in a separate order rule on the specific objections raised by Roux.

I. FDA’s Authority to Search and Collect Samples

21 U.S.C. § 374(a), (c), and (d) authorizes FDA agents to conduct reasonable searches and inspections of the premises of businesses and establishments regulated by the act, and to collect samples for testing and examination. See 21 U.S.C. § 372(a) and (b). United States v. 75 Cases, More or Less, Each Containing 24 Jars of Peanut Butter, 146 F.2d 124, 128 (4th Cir. 1944), cert, denied 325 U.S. 856, 65 S.Ct. 1183, 89 L.Ed. 1976 (1945); United States v. El Rancho Adolphus Prods., 140 F.Supp. 645, 651 (M.D.Pa.1956), aff’d 243 F.2d 367 (3d Cir. 1957), cert, denied 353 U.S. 976, 77 S.Ct. 1058, 1 L.Ed.2d 1136 (1957); United States v. 43V2 Gross Rubber Prophylactics, 65 F.Supp. 534, 536 (D.Minn.1946), aff’d sub nom. Gellman v. United States, 159 F.2d 881 (8th Cir. 1947). 21 U.S.C. § 331(f) prohibits the refusal to permit such inspections, and § 333(a) imposes a penalty of one year or $1,000.00 fine or both, making such refusal a misdemeanor. Finally, under unique circumstances not present here, FDA agents had the right to examine and test all of the items regulated, not merely representative samples. United States v. Various Cases of Adulterated Alcoholic Beverages, 421 F.Supp. 1,2 (D.Alaska 1976). There is no question, therefore, that FDA agents have the authority to conduct administrative searches and inspections, collecting representative samples for testing and examination; the Court so holds.

II. Reasonableness of Eight Ounce Samples

21 U.S.C. § 372(b) requires that, upon request, FDA agents provide a part of *976 each representative sample collected for examination or analysis to be provided to the owner. Triangle Candy Co. v. United States, 144 F.2d 195, 198 (9th Cir. 1944); United States v. Acri Wholesale Grocery Co., 409 F.Supp. 529, 533-34 (S.D.Iowa 1976); United States v. Kendall Co., 324 F.Supp. 628, 630 (D.Mass.1971), Having considered all of the testimony presented to Judge Schlesinger, the Court agrees with him that, in order to meet the requirements of § 372(b) to provide a part of each sample collected to Roux, an eight ounce total sample is not an unreasonable amount. Roux replied that, in view of the ability of many chemical tests to be performed on far smaller sample .amounts, FDA ought to specify what tests and examinations it intends to run. The short answer to that reply, however, is that the statute authorizes FDA to conduct tests and examinations, and delegates to FDA the discretion to determine what tests and examinations to run. In short, what tests FDA might conduct is a matter of its own statutory business, and not a question with which Roux can properly be concerned. The Court, therefore, holds that eight ounce samples are reasonable amounts to be collected by FDA agents.

III. Harassment of Roux by FDA Searches

Roux contends that the administrative search warrant, and attempted search, in 1975, together with the later search warrant in October, 1977, and attempted search, constitute harassment by the government against Roux. To support that contention, Roux points to litigation out in California between the government and itself. This Court, however, does not view the litigation out in California between Roux and the government as in any way affecting the right of the FDA to obtain a search warrant here, and the duty of Roux to obey such a search warrant for the inspection of its facilities within the Middle District of Florida. Whatever may have transpired between Roux and the government in California is irrelevant to the rights and duties stemming from a valid search warrant issued by this Court. Consequently, the Court agrees with Judge Schlesinger, and therefore holds, that two separate inspections, pursuant to valid administrative search warrants, issued more than two years apart, “cannot be considered” harassment. In other words, the FDA is merely carrying out its statutory and regulatory obligations.

One of the FDA’s duties is to ensure that products are not misbranded in their labeling and contents. 21 U.S.C. § 362. A cosmetic is “deemed to be misbranded if its labeling is false or misleading in any particular.” 21 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
456 F. Supp. 973, 1978 U.S. Dist. LEXIS 15659, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-roux-laboratories-inc-flmd-1978.